|
 |
|
|
|||
|
 |
|
Oct. 31, 2011 Source: BIO news release Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood announced that Dr. Cathleen Enright is joining the organization on November 7th as executive vice president, Food and Agriculture. Dr. Enright comes to BIO directly from the Western Growers Association (WGA) where she served as vice president for Federal Government Affairs. Prior to her time at WGA, Dr. Enright spent 12 years working in government agencies. From 1995 to 2000, she served as a policy analyst at the U.S. State Department in the Office of Environment and Scientific Affairs where she negotiated treaties impacting agricultural trade including the Cartegena Protocol on Biosafety. Enright previously held the position of assistant deputy administrator of USDA's Animal and Plant Health Inspection Service (APHIS), managing a staff of 40 and serving as the chief negotiator for the resolution of the phytosanitary trade barriers. From 2006 to 2007, she was the deputy assistant U.S. trade representative where she led many trade policy initiatives that impacted the agricultural industry, including the Sanitary and Phytosanitary (SPS) chapter of the Korea Free Trade Agreement. She also served as the U.S. Representative to the World Trade Organization's SPS Committee. Dr. Enright earned a PhD in biochemistry from the State University of New York and completed her post-doctoral training at The Johns Hopkins University School of Medicine. "We are proud to welcome Cathy to BIO," said Greenwood. "Her considerable experience in agricultural policy - as well as her scientific expertise - will be a tremendous asset for members of our Food & Agriculture Section. The need for modern agriculture technologies has never been greater, and under Cathy's leadership, we can create a better understanding of and appreciation for the benefits of agricultural biotechnology. "We are very pleased to add both of these distinguished and talented individuals to the BIO team. I know that the contributions they will make to our industry and our organization will be substantial as we work to heal, fuel and feed the world." About BIO BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
